Unlike in physiological conditions where the CaSR acts to reduce bone degradation in situations of increased Ca2+ levels, in breast cancer cells, the CaSR acts to promote further bone resorption and an elevated systemic concentration of Ca2+ ions in response to an increase in the Ca2+ ion concentration [21]. This evidence concerns the gene CASR and breast carcinoma.